Development Level

Tbio 2 | 10,625
Tclin 1 | 602

Disease

Breast cancer 3 | 3,094
Cancer 3 | 2,346
Mammary Neoplasms 3 | 410
pancreatic cancer 3 | 2,300
Adenocarcinoma 2 | 115
Carcinoma 2 | 2,147
Disease Progression 2 | 125
Glioma 2 | 65
Kidney disease 2 | 396
Lung Neoplasms 2 | 171
Neoplasm Metastasis 2 | 138
Neoplastic Cell Transformation 2 | 81
Peripheral Neuropathy 2 | 303
Prostatic Neoplasms 2 | 471
ductal carcinoma in situ 2 | 1,745
interstitial cystitis 2 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
invasive ductal carcinoma 2 | 2,950
lung carcinoma 2 | 2,844
nasopharyngeal carcinoma 2 | 1,056
psoriasis 2 | 6,685
ulcerative colitis 2 | 2,087
Adenocarcinoma of lung (disorder) 1 | 48
Adenoma 1 | 165
Alopecia 1 | 55
Alzheimer's disease 1 | 644
Anemia 1 | 252
Animal Mammary Neoplasms 1 | 136
Autistic Disorder 1 | 320
Barrett's esophagus 1 | 183
Beta thalassemia 1 | 19
Bladder Neoplasm 1 | 109
Breast disease 1 | 8
Breast fibroadenoma 1 | 8
Carcinogenesis 1 | 6
Cholangiocarcinoma 1 | 32
Chronic Lymphocytic Leukemia 1 | 242
Cleft palate 1 | 125
Colonic Neoplasms 1 | 126
Colorectal Neoplasms 1 | 217
Comedo carcinoma 1 | 2
Diarrhea 1 | 155
Esophageal Neoplasms 1 | 67
Exanthem 1 | 39
Eye disease 1 | 55
GLIOMA SUSCEPTIBILITY 1 1 | 3
Gastrointestinal Neoplasms 1 | 4
Gastrointestinal system disease 1 | 50
HER2 Positive Carcinoma of Breast 1 | 2
HER2-positive carcinoma of breast 1 | 10
Heart disease 1 | 279
Helicobacter Infections 1 | 5
Human immunodeficiency virus infectious disease 1 | 92
Hypersensitivity reaction type II disease 1 | 235
Inflammation 1 | 109
Iron Metabolism Disorders 1 | 5
Iron metabolism disease 1 | 17
Kidney Diseases 1 | 86
Kidney cancer 1 | 118
Liver carcinoma 1 | 217
Lobular neoplasia 1 | 15
Lymphatic Metastasis 1 | 14
Lymphoma, Non-Hodgkin 1 | 22
Malaria 1 | 140
Mammary Neoplasms, Experimental 1 | 150
Myocardial Reperfusion Injury 1 | 34
Neoplasm Invasiveness 1 | 127
Neoplasm Recurrence, Local 1 | 23
Neoplasms, Experimental 1 | 33
Neuroblastoma 1 | 78
Neurodegenerative disease 1 | 383
Neuropathy 1 | 210
Neutropenia 1 | 78
Non-small cell lung cancer, positive for epidermal growth factor receptor expression 1 | 4
Papilloma 1 | 27
Peripheral vascular disease 1 | 90
Pleomorphic adenoma 1 | 18
Polycystic Ovary Syndrome 1 | 332
Polycystic kidney disease 1 | 54
Precancerous Conditions 1 | 69
Pulmonary Fibrosis 1 | 66
Renal Cell Carcinoma 1 | 199
Reperfusion Injury 1 | 84
Secondary malignant neoplasm of female breast 1 | 3
Severe Combined Immunodeficiency 1 | 46
Spontaneous abortion 1 | 108
Stomach Neoplasms 1 | 282
Stomatitis 1 | 19
Thalassemia 1 | 46
Thrombocytopenia 1 | 105
Vascular disease 1 | 281
atypical teratoid/rhabdoid tumor 1 | 1,095
breast carcinoma 1 | 1,614
gallbladder neoplasm 1 | 9
medulloblastoma 1 | 1,524
non-small cell lung carcinoma 1 | 413
ovarian neoplasm 1 | 97
progressive supranuclear palsy 1 | 674
type II diabetes mellitus and post-ischemic heart failure 1 | 89

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 2 | 11,971
Kinase 1 | 634

Grant Application

5R21GM058235-02 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Pro-epidermal growth factor EGF Tbio Non-IDG -3.74376 4837.7 851
Receptor tyrosine-protein kinase erbB-2 ERBB2 Tclin Kinase -4.22922 19000.3 3336